Jazz Pharmaceuticals plc — Director's Dealing 2021

Aug 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2021-08-18

Reporting Person: ENRIGHT PATRICK G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-18	Ordinary Shares	A	2000	$137.75	Acquired	2000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	22614	Direct

Footnotes

F1: These shares are held by a trust (the "Trust"). Reporting person is the Trustee of the Trust and may be deemed to share voting, investment and dispositive power over the shares held by the Trust. Reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein and this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.